Brief: Novabay Pharmaceuticals Reports First Quarter 2023 Financial Results
11/05/2023 21:37
NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS
* NOVABAY PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.85
Source text for Eikon: ID:nBw6pkPxBa
Further company coverage: NBY.A
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing